Replicel Life Sciences Inc (RP.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2007 | 12-2006 | 12-2005 | 12-2004 | 12-2003 | |
| Operating Expenses | 371 | 491 | 300 | 519 | 94 |
| Operating Income | -371 | -491 | -300 | -519 | -94 |
| Other Income | -230 | 201 | -191 | 519 | 94 |
| Pre-tax Income | -601 | -290 | -491 | N/A | N/A |
| Income Tax | N/A | N/A | -64 | N/A | N/A |
| Net Income Continuous | -601 | -290 | -428 | -984 | -105 |
| Net Income | $-601 | $-290 | $-428 | $-984 | $-105 |
| EPS Basic Total Ops | -0.20 | -0.10 | -0.10 | -0.30 | -0.30 |
| EPS Basic Continuous Ops | -0.20 | -0.10 | -0.10 | -0.30 | -0.30 |
| EPS Diluted Total Ops | -0.20 | -0.10 | -0.10 | -0.30 | -0.30 |
| EPS Diluted Continuous Ops | -0.20 | -0.10 | -0.10 | -0.30 | -0.30 |
| EBITDA(a) | $-371 | $-491 | $-300 | $-519 | $-94 |